Home › Funds › Rock Springs Capital Management LP › CYTK
Rock Springs Capital Management LP position in CYTK
CYTOKINETICS INC · Health Care
Rock Springs Capital Management LP reported holding 201,839 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$13.3M, representing 0.72% of its reported portfolio and ranking #46 among its reported holdings. Rock Springs Capital Management LP has disclosed CYTK holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rock Springs Capital Management LP's CYTK position evolved
Rock Springs Capital Management LP first disclosed a stake in CYTK in Q3 2023 at 134,252 shares (US$4.0M). The position peaked in Q2 2026 at 187,980 shares, worth US$16.0M. Across 6 filings, Rock Springs Capital Management LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 201,839 shares valued at US$13.3M — an increase of 13,859 shares quarter over quarter.. Notable position changes include a 27% increase in Q1 2026 (shares rose 29% over the following quarter), a 314% increase in Q2 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 134.25K | $3.96M | New |
| Q3 2024 | 206.11K | $10.88M | New |
| Q4 2025 | 35.85K | $2.28M | New |
| Q1 2026 | 45.36K | $2.99M | Add |
| Q2 2026 | 187.98K | $16.01M | Add |
| Q3 2026 | 201.84K | $13.30M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (CYTOKINETICS INC) is a Health Care company. 40 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$323.0M), Polar Capital Holdings Plc (US$227.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 4.90M sh · $322.96M · Q3 2026
- Polar Capital Holdings Plc 9.64M sh · $227.69M · Q3 2026
- RTW INVESTMENTS, LP 2.86M sh · $188.63M · Q3 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.18M sh · $77.79M · Q3 2026
- Integral Health Asset Management, LLC 1.60M sh · $72.50M · Q3 2026
- GW&K Investment Management, LLC 1.02M sh · $67.08M · Q3 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $64.62M · Q3 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
- Melqart Asset Management (UK) Ltd 761.54K sh · $50.19M · Q3 2026
- Affinity Asset Advisors, LLC 750.00K sh · $49.43M · Q3 2026
More on Rock Springs Capital Management LP
FAQ
How long has Rock Springs Capital Management LP held CYTK?
Rock Springs Capital Management LP has disclosed CYTK holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is Rock Springs Capital Management LP's current position in CYTK?
As of Q3 2026, Rock Springs Capital Management LP holds 201.84K shares of CYTK (CYTOKINETICS INC), valued at $13.30M, representing 0.72% of its reported portfolio and ranking #46.
Has Rock Springs Capital Management LP been buying or selling CYTK?
In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in CYTK. The position peaked in Q2 2026 at 187.98K shares.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, Polar Capital Holdings Plc, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.